523 related articles for article (PubMed ID: 27659805)
1. A Case Report of Penile Infection Caused by Fluconazole- and Terbinafine-Resistant Candida albicans.
Hu Y; Hu Y; Lu Y; Huang S; Liu K; Han X; Mao Z; Wu Z; Zhou X
Mycopathologia; 2017 Apr; 182(3-4):397-402. PubMed ID: 27659805
[TBL] [Abstract][Full Text] [Related]
2. In vitro activities of terbinafine in combination with fluconazole and itraconazole against isolates of Candida albicans with reduced susceptibility to azoles.
Barchiesi F; Falconi Di Francesco L; Scalise G
Antimicrob Agents Chemother; 1997 Aug; 41(8):1812-4. PubMed ID: 9257768
[TBL] [Abstract][Full Text] [Related]
3. [Antifungal susceptibility testing of commensal and pathogenic clinical isolates of oral Candida].
Zhao M; Zhou ZT
Shanghai Kou Qiang Yi Xue; 2006 Apr; 15(2):218-20. PubMed ID: 16685371
[TBL] [Abstract][Full Text] [Related]
4. In vitro susceptibility of Candida albicans clinical isolates to eight antifungal agents in Ouagadougou (Burkina Faso).
Zida A; Yacouba A; Bamba S; Sangare I; Sawadogo M; Guiguemde T; Kone S; Traore LK; Ouedraogo-Traore R; Guiguemde RT
J Mycol Med; 2017 Dec; 27(4):469-475. PubMed ID: 28754462
[TBL] [Abstract][Full Text] [Related]
5. In-vitro interaction of terbinafine with amphotericin B, fluconazole and itraconazole against clinical isolates of Candida albicans.
Barchiesi F; Di Francesco LF; Compagnucci P; Arzeni D; Giacometti A; Scalise G
J Antimicrob Chemother; 1998 Jan; 41(1):59-65. PubMed ID: 9511038
[TBL] [Abstract][Full Text] [Related]
6. Activity of amphotericin B, anidulafungin, caspofungin, micafungin, posaconazole, and voriconazole against Candida albicans with decreased susceptibility to fluconazole from APECED patients on long-term azole treatment of chronic mucocutaneous candidiasis.
Rautemaa R; Richardson M; Pfaller MA; Perheentupa J; Saxén H
Diagn Microbiol Infect Dis; 2008 Oct; 62(2):182-5. PubMed ID: 18597968
[TBL] [Abstract][Full Text] [Related]
7. [25S rDNA genotype and antifungal susceptibility of vaginal Candida albicans].
Zhang X; Liu ZH
Zhonghua Fu Chan Ke Za Zhi; 2016 Apr; 51(4):279-84. PubMed ID: 27116986
[TBL] [Abstract][Full Text] [Related]
8. Candida spp. in vitro susceptibility profile to four antifungal agents. Resistance surveillance study in Venezuelan strains.
Panizo MM; Reviákina V; Dolande M; Selgrad S
Med Mycol; 2009 Mar; 47(2):137-43. PubMed ID: 18651308
[TBL] [Abstract][Full Text] [Related]
9. Azole resistance in Candida albicans.
Smith KJ; Warnock DW; Kennedy CT; Johnson EM; Hopwood V; Van Cutsem J; Vanden Bossche H
J Med Vet Mycol; 1986 Apr; 24(2):133-44. PubMed ID: 3014106
[TBL] [Abstract][Full Text] [Related]
10. In Candida albicans, resistance to flucytosine and terbinafine is linked to MAT locus homozygosity and multilocus sequence typing clade 1.
Odds FC
FEMS Yeast Res; 2009 Oct; 9(7):1091-101. PubMed ID: 19799637
[TBL] [Abstract][Full Text] [Related]
11. Possible mechanisms of the antifungal activity of fluconazole in combination with terbinafine against Candida albicans.
Khodavandi A; Alizadeh F; Vanda NA; Karimi G; Chong PP
Pharm Biol; 2014 Dec; 52(12):1505-9. PubMed ID: 24863276
[TBL] [Abstract][Full Text] [Related]
12. Antifungal drug resistance in pathogenic fungi.
Vanden Bossche H; Dromer F; Improvisi I; Lozano-Chiu M; Rex JH; Sanglard D
Med Mycol; 1998; 36 Suppl 1():119-28. PubMed ID: 9988500
[TBL] [Abstract][Full Text] [Related]
13. Increasing Susceptibility of Drug-Resistant
Sharafutdinov IS; Ozhegov GD; Sabirova AE; Novikova VV; Lisovskaya SA; Khabibrakhmanova AM; Kurbangalieva AR; Bogachev MI; Kayumov AR
Molecules; 2020 Feb; 25(3):. PubMed ID: 32024254
[TBL] [Abstract][Full Text] [Related]
14. Dynamic analysis of oral Candida carriage, distribution, and antifungal susceptibility in HIV-infected patients during the first year of highly active antiretroviral therapy in Guangxi, China.
Jiang L; Yong X; Li R; Peng Y; Liu W; Qin Q; Zhang L; Liu Z; Liang H; Tao R
J Oral Pathol Med; 2014 Oct; 43(9):696-703. PubMed ID: 24931443
[TBL] [Abstract][Full Text] [Related]
15. In vitro inhibitory effects of farnesol and interactions between farnesol and antifungals against biofilms of Candida albicans resistant strains.
Xia J; Qian F; Xu W; Zhang Z; Wei X
Biofouling; 2017 Apr; 33(4):283-293. PubMed ID: 28317391
[TBL] [Abstract][Full Text] [Related]
16. Characterization of mechanisms of fluconazole resistance in a Candida albicans isolate from a Japanese patient with chronic mucocutaneous candidiasis.
Kamai Y; Maebashi K; Kudoh M; Makimura K; Naka W; Uchida K; Yamaguchi H
Microbiol Immunol; 2004; 48(12):937-43. PubMed ID: 15611610
[TBL] [Abstract][Full Text] [Related]
17. In vitro susceptibility of oral Candida to seven antifungal agents.
Kuriyama T; Williams DW; Bagg J; Coulter WA; Ready D; Lewis MA
Oral Microbiol Immunol; 2005 Dec; 20(6):349-53. PubMed ID: 16238594
[TBL] [Abstract][Full Text] [Related]
18. Resistance Surveillance in Candida albicans: A Five-Year Antifungal Susceptibility Evaluation in a Brazilian University Hospital.
Peron IH; Reichert-Lima F; Busso-Lopes AF; Nagasako CK; Lyra L; Moretti ML; Schreiber AZ
PLoS One; 2016; 11(7):e0158126. PubMed ID: 27414653
[TBL] [Abstract][Full Text] [Related]
19. Azole-resistant Candida albicans: report of two cases of resistance to fluconazole and review.
White A; Goetz MB
Clin Infect Dis; 1994 Oct; 19(4):687-92. PubMed ID: 7803633
[TBL] [Abstract][Full Text] [Related]
20. The synergy of honokiol and fluconazole against clinical isolates of azole-resistant Candida albicans.
Jin J; Guo N; Zhang J; Ding Y; Tang X; Liang J; Li L; Deng X; Yu L
Lett Appl Microbiol; 2010 Sep; 51(3):351-7. PubMed ID: 20681969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]